- Home
- WFRD vs ASND Comparison
WFRD vs ASND Comparison
Compare WFRD & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFRD
- ASND
- Stock Information
- Founded
- WFRD 1941
- ASND 2006
- Country
- WFRD United States
- ASND Denmark
- Employees
- WFRD N/A
- ASND 1017
- Industry
- WFRD Metal Fabrications
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- WFRD Industrials
- ASND Health Care
- Exchange
- WFRD Nasdaq
- ASND Nasdaq
- Market Cap
- WFRD 4.1B
- ASND 12.1B
- IPO Year
- WFRD N/A
- ASND 2015
- Fundamental
- Price
- WFRD $65.50
- ASND $199.37
- Analyst Decision
- WFRD Strong Buy
- ASND Strong Buy
- Analyst Count
- WFRD 7
- ASND 16
- Target Price
- WFRD $92.71
- ASND $240.75
- AVG Volume (30 Days)
- WFRD 804.1K
- ASND 370.3K
- Earning Date
- WFRD 10-21-2025
- ASND 11-13-2025
- Dividend Yield
- WFRD 1.53%
- ASND N/A
- EPS Growth
- WFRD N/A
- ASND N/A
- EPS
- WFRD 6.50
- ASND N/A
- Revenue
- WFRD $5,147,000,000.00
- ASND $576,332,355.00
- Revenue This Year
- WFRD N/A
- ASND $102.31
- Revenue Next Year
- WFRD $0.81
- ASND $76.44
- P/E Ratio
- WFRD $10.07
- ASND N/A
- Revenue Growth
- WFRD N/A
- ASND 54.50
- 52 Week Low
- WFRD $36.74
- ASND $118.03
- 52 Week High
- WFRD $98.21
- ASND $208.16
- Technical
- Relative Strength Index (RSI)
- WFRD 64.23
- ASND 57.01
- Support Level
- WFRD $61.20
- ASND $193.00
- Resistance Level
- WFRD $65.95
- ASND $200.55
- Average True Range (ATR)
- WFRD 2.24
- ASND 5.87
- MACD
- WFRD -0.02
- ASND -0.85
- Stochastic Oscillator
- WFRD 92.13
- ASND 48.20
About WFRD Weatherford International plc
Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.